Amgen Inc. Data Breach – Investigated by Federman & Sherwood
August 19, 2026 – Federman & Sherwood, a national consumer protection law firm, is investigating the Amgen Inc. data breach following a notification filed with the Texas Attorney General.
According to the Texas filing, the data breach affected approximately 6,714 Texas residents, with additional individuals potentially affected nationwide. The information potentially affected includes names, addresses, Social Security numbers, driver’s license numbers, government-issued identification numbers, financial information, medical information, health insurance information, and dates of birth.
The exposure of this combination of sensitive personal, financial, and medical information may increase the risk of identity theft, financial fraud, medical identity theft, and other forms of misuse.
Federman & Sherwood is investigating whether Amgen Inc. implemented reasonable cybersecurity safeguards to protect sensitive personal information and whether additional security measures could have prevented this incident. The firm is also evaluating potential legal claims on behalf of affected individuals.
The potentially compromised information may include:
- Names
- Social Security numbers
- Dates of birth
- Addresses
- Driver’s license numbers
- Government-issued identification numbers
- Financial information
- Medical information
- Health insurance information
- Other sensitive information
What is Amgen Inc.?
Amgen is a global biotechnology company that discovers, develops, and manufactures human medicines using advanced cellular and molecular biology.
Individuals affected by the Amgen Inc. data breach may have legal rights and are encouraged to contact Federman & Sherwood to learn more about their options.
Phone: 1-800-237-1277 | Email: info@federmanlaw.com